Herzliya, Israel

Abi Vainstein-haras

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Abi Vainstein-Haras: Innovator in Cancer Treatment

Introduction

Abi Vainstein-Haras is a notable inventor based in Herzliya, Israel. He has made significant contributions to the field of cancer treatment, particularly focusing on metastatic pancreatic adenocarcinoma. His innovative approach combines various therapeutic agents to improve patient outcomes.

Latest Patents

Vainstein-Haras holds a patent for a method of treating metastatic pancreatic adenocarcinoma. This method involves administering a therapeutically effective amount of a specific peptide, an anti PD-1, and chemotherapy to patients in need. His patent represents a promising advancement in the fight against this aggressive form of cancer. He has 1 patent to his name.

Career Highlights

Throughout his career, Abi Vainstein-Haras has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Biolinerx Ltd. and Merck Sharp & Dohme Corporation. His work in these organizations has allowed him to develop and refine his innovative treatment methods.

Collaborations

Vainstein-Haras has collaborated with several professionals in his field. Among his notable coworkers are Ella Sorani and Irit Gliko-Kabir, who have contributed to his research and development efforts.

Conclusion

Abi Vainstein-Haras is a pioneering inventor whose work in cancer treatment is making a significant impact. His innovative methods and collaborations highlight the importance of teamwork in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…